Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

A Phase 1 Study of LNCB74 in Advanced Solid TumorsRecruiting
NCT06774963Phase 1Updated Aug 21, 2026
Sponsor: NextCure, Inc.
Ovarian Cancer · Breast Cancer · Endometrial Cancer · Biliary Tract Cancer
United States
Phase IIIb Study of Ribociclib + ET in Early Breast CancerRecruiting
NCT05827081Phase 3Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Early Breast Cancer
United States, Argentina, Australia, Brazil, Canada +11 more
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial HypertensionCompleted
NCT06137742Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Pfizer
Pulmonary Arterial Hypertension
United States, Australia, Belgium, China, Czechia +7 more
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerRecruiting
NCT07169851Phase 2Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Nausea · Vomiting · Drug-Related Side Effects and Adverse Reactions · Neoplasms
United States, Australia, China, France, Italy +5 more
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal CancersActive Not Recruiting
NCT02466971Phase 3Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Vaginal Adenocarcinoma · Advanced Vaginal Adenosquamous Carcinoma · Advanced Vaginal Squamous Cell Carcinoma · Cervical Adenocarcinoma
United States, Canada, Puerto Rico
A Study of LTX-001 In Adult Participants With Acute Exacerbation of SchizophreniaRecruiting
NCT07734493Phase 1Updated Aug 21, 2026
Sponsor: Leal Therapeutics, Inc
Schizophrenia
United States
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 DiabetesRecruiting
NCT07321886Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Obesity · Overweight
United States, Argentina, Australia, Belgium, Brazil +10 more
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell MalignanciesRecruiting
NCT06634589Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: BeOne Medicines
B-cell Malignancy · Relapsed Cancer · Refractory Cancer · B-cell Lymphoma
United States, Australia, Brazil, China, Germany +3 more
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)Recruiting
NCT04419649Phase 2Updated Aug 21, 2026
Sponsor: Takeda
Myelodysplastic Syndromes · Cytopenia
United States, Australia, Czechia, France, Germany +3 more
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia GravisRecruiting
NCT07294170N/AUpdated Aug 21, 2026
Sponsor: argenx
Myasthenia Gravis · MG · gMG · Generalized Myasthenia Gravis
United States, Belgium, Germany, Greece, Italy +3 more
Coronary Atherosclerosis T1-Weighted Characterization (CATCH)Recruiting
NCT03504956NAUpdated Aug 21, 2026
Sponsor: Cedars-Sinai Medical Center
Coronary Atherosclerosis
United States
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationRecruiting
NCT06952803Phase 3Updated Aug 21, 2026
Sponsor: AstraZeneca
Prostate Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
A Study of ZL-1310 in Subjects With Small Cell Lung CancerRecruiting
NCT06179069Phase 1Updated Aug 21, 2026
Sponsor: Zai Lab (Shanghai) Co., Ltd.
SCLC
United States, China, Spain
Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 MutationSuspended
NCT03728335Phase 2Updated Aug 21, 2026
Sponsor: City of Hope Medical Center
Acute Myeloid Leukemia
United States
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate CancerRecruiting
NCT07005154Phase 2Updated Aug 21, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Prostate Cancer · Metastatic Castration-Resistant Prostate Cancer · Metastatic Hormone Sensitive Prostate Cancer
United States, China, France, Germany, Italy +7 more
Implementation Strategies for Self-Measured Blood Pressure Monitoring in Racially and Ethnically Diverse PopulationsEnrolling By Invitation
NCT06871462NAUpdated Aug 21, 2026
Sponsor: University of California, San Francisco
Blood Pressure Monitoring, Home · Hypertension
United States
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung CancerRecruiting
NCT05061550Phase 2Updated Aug 21, 2026
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, Belgium, Canada, France, Hungary +7 more
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLPEnrolling By Invitation
NCT05883748Phase 2, Phase 3Updated Aug 21, 2026
Sponsor: Disc Medicine, Inc
Erythropoietic Protoporphyria
United States, Australia, Belgium, France, Germany +3 more
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus NephritisActive Not Recruiting
NCT05126277Phase 3Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Lupus Nephritis
United States, Argentina, Brazil, Canada, Chile +22 more
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet SyndromeRecruiting
NCT05419492Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Encoded Therapeutics
Dravet Syndrome
United States, Australia, United Kingdom
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationRecruiting
NCT04858334Phase 2Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Pancreatic Acinar Cell Carcinoma · Pancreatic Adenosquamous Carcinoma · Pancreatic Squamous Cell Carcinoma · Resectable Pancreatic Acinar Cell Carcinoma
United States, Israel, Puerto Rico
Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis SuppurativaCompleted
NCT04179175Phase 3Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +33 more
An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusEnrolling By Invitation
NCT05352919Phase 3Updated Aug 21, 2026
Sponsor: Biogen
Systemic Lupus Erythematosus (SLE)
United States, Argentina, Belgium, Brazil, Bulgaria +23 more
Wearable Sensor for Early Detection and Monitoring of Cognitive DeclineNot Yet Recruiting
NCT07780162N/AUpdated Aug 21, 2026
Sponsor: BioSensics
Mild Cognitive Impairment (MCI) · Older Adults With Cognitive Decline · Older Adults
United States
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaRecruiting
NCT06317662Phase 2Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Acute Leukemia of Ambiguous Lineage · B Acute Lymphoblastic Leukemia
United States, Puerto Rico

Previous page Next page